Blog - Advanced Medicine In China

1 year ago

Carvykti EMA Approved It For Second-Line Treatment of Patients with Relapsed or Refractory Multiple Myeloma(MM)

Carvykti EMA Approved It For Second-Line Treatment of Patients with Relapsed or Refractory Multiple Myeloma(MM) On February 23, 2024, the European Medicines Agency (EMA) released the highlights of ...

1 year ago

Cross-Border Medical Innovation: Singaporean Patient Confronts Multiple Myeloma in China – A Decisive Journey with CAR-T Therapy

Cross-Border Medical Innovation: Singaporean Patient Confronts Multiple Myeloma in China – A Decisive Journey with CAR-T Therapy Multiple Myeloma Singaporean patient, Teresa has been batt...

1 year ago

Carvykti Price and Brief Introduction

Carvykti Price and Brief Introduction Ciltacabtagene Autoleucel, a CAR-T product from China, received FDA approval in March 2022 and EU approval on May 26th of the same year, marking an unprecedent...

1 year ago

跨境医疗创新：新加坡患者在中国迎战骨髓瘤——一次CAR-T治疗的决定性旅程

跨境医疗创新：新加坡患者在中国迎战骨髓瘤——一次CAR-T治疗的决定性旅程多发性骨髓瘤，患者故事新加坡患者Teresa女士，经历了近三年与多发性骨髓瘤的斗争，她目前在多线药物治疗、放化疗后仍面临病...

1 year ago

Carvykti FDA Approval for the Treatment of Relapsed or Refractory Multiple Myeloma

Carvykti FDA Approval for the Treatment of Relapsed or Refractory Multiple Myeloma FDA Approves The Listing Of Carvykti On February 28, 2022, Legend Biotech Corporation (LEGN) announced that the U....

1 year ago

Journey of an Indian Cancer Patient to China: Bringing Gratitude Back to India!

🍒🍎Journey of an Indian Cancer Patient to China: Bringing Gratitude Back to India!🍒🍎 Cancer Patient 🍅“Before coming to China for treatment, I had many concerns because my condition was very pe...

1 year ago

Preparations Before Myeloma CAR-T Therapy: Dual Evaluation of Physical Condition and Disease Status to Ensure Smooth Treatment

Preparations Before Myeloma CAR-T Therapy: Dual Evaluation of Physical Condition and Disease Status to Ensure Smooth Treatment Dear readers, if you or someone around you is about to undergo CAR-T c...

1 year ago

Multiple Myeloma CAR-T Treatment Strategy:From Preparation TO Management,One Can Understand!

Multiple Myeloma CAR-T Treatment Strategy:From Preparation TO Management,One Can Understand! Would you like to understand the entire process of CAR-T cell infusion? This comprehensive guide covers ...

1 year ago

$160,000 per dose! The first approved CAR-T therapy in China, Zevor-cel by CARsgen, announces its initial price for the treatment of multiple myeloma.

🌈 $160,000 per dose! 🌈 ⭐The first approved CAR-T therapy in China, Zevor-cel by CARsgen, announces its initial price for the treatment of multiple myeloma. multiple myeloma Zevor-cel ...

1 year ago

Carvykti(Ciltacabtagene Autoleucel) Recommended for Approval by CHMP for Front-line Treatment of Multiple Myeloma

Carvykti(Ciltacabtagene Autoleucel) Recommended for Approval by CHMP for Front-line Treatment of Multiple Myeloma On February 23, 2024, Legend Biotech announced that the Committee for Medicinal Pro...

1 year ago

Carvykti(Ciltacabtagene Autoleucel):A Breakthrough in CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma

Carvykti(Ciltacabtagene Autoleucel):A Breakthrough in CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Legend Biotech and Janssen Biotech Inc. entered into a collaboration agreement in D...

1 year ago

Chinese Medicine Team Achieves Global Milestone: First Successful Treatment of Pancreatic Cancer Patient with Innovative Dual-Targeted CAR-T Cell Therapy (KD-496)!

🎉 Chinese Medicine Team Achieves Global Milestone: First Successful Treatment of Pancreatic Cancer Patient with Innovative Dual-Targeted CAR-T Cell Therapy (KD-496)! Dual-Targeted CAR-T ...

Menu

Our Blog